Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs

Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B . Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabol...

Full description

Saved in:
Bibliographic Details
Published inDrug testing and analysis Vol. 16; no. 12; p. 1436
Main Authors Jędrejko, Karol, Catlin, Oliver, Stewart, Timothy, Muszyńska, Bożena
Format Journal Article
LanguageEnglish
Published England 01.12.2024
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B . Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabolism. The use of Mexidol by Russian athletes has been confirmed in the past. Current use by athletes is unknown as this drug is not monitored or included in drug testing protocol. Metabotropic and antihypoxic effects of Mexidol were compared to the effects of meldonium or trimetazidine, both of which are included on the World Anti-Doping Agency (WADA) Prohibited List in category S4.4. Metabolic Modulators. The conjugation of emoxypine with succinate elevates the therapeutic effectiveness of the Mexidol formulation as succinic acid itself has important impacts to consider despite being a common food additive and drug excipient. Other succinic acid salts like ammonium succinate, found as dietary supplement, have been patented as performance enhancers. Available research on healthy subjects suggests that combinations of selected 3-substituted pyridine derivatives with succinate including Mexidol and a related drug Cytoflavin can enhance the performance of athletes. Cytoflavin is a multi-component formula containing meglumine sodium succinate, nicotinamide (vitamin B ), inosine (riboxin), and riboflavin. Other related succinate-based drugs include Remaxol, Reamberin, and Cogitum. Mexidol and Cytoflavin and related substances exhibit similar biological effects as drugs on the WADA Prohibited List, and if they are used for performance enhancement by athletes, they could be worthy of consideration as prohibited substances in sport.
AbstractList Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B . Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabolism. The use of Mexidol by Russian athletes has been confirmed in the past. Current use by athletes is unknown as this drug is not monitored or included in drug testing protocol. Metabotropic and antihypoxic effects of Mexidol were compared to the effects of meldonium or trimetazidine, both of which are included on the World Anti-Doping Agency (WADA) Prohibited List in category S4.4. Metabolic Modulators. The conjugation of emoxypine with succinate elevates the therapeutic effectiveness of the Mexidol formulation as succinic acid itself has important impacts to consider despite being a common food additive and drug excipient. Other succinic acid salts like ammonium succinate, found as dietary supplement, have been patented as performance enhancers. Available research on healthy subjects suggests that combinations of selected 3-substituted pyridine derivatives with succinate including Mexidol and a related drug Cytoflavin can enhance the performance of athletes. Cytoflavin is a multi-component formula containing meglumine sodium succinate, nicotinamide (vitamin B ), inosine (riboxin), and riboflavin. Other related succinate-based drugs include Remaxol, Reamberin, and Cogitum. Mexidol and Cytoflavin and related substances exhibit similar biological effects as drugs on the WADA Prohibited List, and if they are used for performance enhancement by athletes, they could be worthy of consideration as prohibited substances in sport.
Author Stewart, Timothy
Jędrejko, Karol
Catlin, Oliver
Muszyńska, Bożena
Author_xml – sequence: 1
  givenname: Karol
  orcidid: 0000-0001-5301-2396
  surname: Jędrejko
  fullname: Jędrejko, Karol
  organization: Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland
– sequence: 2
  givenname: Oliver
  surname: Catlin
  fullname: Catlin, Oliver
  organization: Banned Substances Control Group (BSCG), Los Angeles, California, USA
– sequence: 3
  givenname: Timothy
  surname: Stewart
  fullname: Stewart, Timothy
  organization: Banned Substances Control Group (BSCG), Los Angeles, California, USA
– sequence: 4
  givenname: Bożena
  surname: Muszyńska
  fullname: Muszyńska, Bożena
  organization: Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38403950$$D View this record in MEDLINE/PubMed
BookMark eNo1kNtqwzAMhs3YWA8b7AmGH6DpnDhJm8tRdoKO3WzXRbHlxiOxg-2U9hH3VnPbDQSSkPg--Cfk0liDhNylbJ4ylj3IAHNeFsUFGadVniWLMk1HZOL9N2NlnvHimoz4Mme8KtiY_LzjXkvbzujqEKxqYafNjIKR1A9CaKMFBaEllej0DoLeoacQywTdHHq712J2WhLtRYNdfO8wQG3b42Tl0EKwzp-J6LZ2iyeklp5qQyE0LYYjMp6FNV5HT7RYQ62ioUHtaG8DRgG0R2-PTlnXgRFI0TSxa7Ol0g1bf0OuFLQeb__6lHw9P32uXpP1x8vb6nGdCL7kRSLkcpGrOl2qagFMsRLqLIbBC8ixElVV1yqHBRdCxoQAMa9QyTytBZepLLMym5L7M7cf6g7lpne6A3fY_Gea_QIRx34m
CitedBy_id crossref_primary_10_1007_s00424_024_02981_6
crossref_primary_10_3390_antiox14010108
crossref_primary_10_31718_2077_1096_24_4_155
crossref_primary_10_3390_foods14050772
ContentType Journal Article
Copyright 2024 John Wiley & Sons Ltd.
Copyright_xml – notice: 2024 John Wiley & Sons Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/dta.3655
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1942-7611
ExternalDocumentID 38403950
Genre Journal Article
Review
GroupedDBID ---
05W
0R~
1OC
31~
33P
4.4
53G
5DZ
5GY
8-0
8-1
A00
AAESR
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAYCA
AAZKR
ABCUV
ABJNI
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACRPL
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFWVQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
CGR
CUY
CVF
DCZOG
DU5
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
FEDTE
G-S
GODZA
HGLYW
HVGLF
HZ~
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MK0
MY.
MY~
NNB
NPM
O9-
OIG
P2P
P2W
P4E
PQQKQ
ROL
SUPJJ
SV3
TUS
WBKPD
WOHZO
WXSBR
WYJ
XV2
ZZTAW
ID FETCH-LOGICAL-c3835-cd874fb18f97a0f06ab240335a4e9c99bbf4a73ccd039aee49efd41bc3d1d6262
IngestDate Wed Jan 15 06:03:32 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords antihypoxants
Cytoflavin
metabolic modulators
Mexidol
actoprotectors
Language English
License 2024 John Wiley & Sons Ltd.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3835-cd874fb18f97a0f06ab240335a4e9c99bbf4a73ccd039aee49efd41bc3d1d6262
ORCID 0000-0001-5301-2396
OpenAccessLink https://ruj.uj.edu.pl/xmlui/handle/item/327012
PMID 38403950
ParticipantIDs pubmed_primary_38403950
PublicationCentury 2000
PublicationDate 2024-Dec
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-Dec
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Drug testing and analysis
PublicationTitleAlternate Drug Test Anal
PublicationYear 2024
SSID ssj0064235
Score 2.3736978
SecondaryResourceType review_article
Snippet Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B . Emoxypine succinate is a registered drug in Russia and Ukraine under various...
SourceID pubmed
SourceType Index Database
StartPage 1436
SubjectTerms Athletes
Doping in Sports - prevention & control
Flavin Mononucleotide - pharmacology
Humans
Inosine Diphosphate - pharmacology
Male
Methylhydrazines - pharmacology
Performance-Enhancing Substances - pharmacology
Picolines - pharmacology
Succinates - pharmacology
Succinic Acid
Title Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs
URI https://www.ncbi.nlm.nih.gov/pubmed/38403950
Volume 16
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fb9MwEMetFRDaC-L3b-QHtpc2o0lcd36EApqQgD100t4mx3a2sDWu2nRa9x_yX3FnOz82DQRIVdTGrRv1PnJ817vvEfI2H-tYxiyO4OYxjlgcm0hoYFmJoQB3DBtNOrXPb3zvgH05HB1u9O50spZWVbajLm-sK_kfq8I5sCtWyf6DZZtJ4QQ8B_vCESwMx7-y8VdzUWjfImuyrmx-Js-9JICLhq-UwqrHvlSF7mu4nnMn8r3E1jLwexYn67m9KJR_f1VEBTi6LlV-ZipAA9WvZ1Zjey_r-6jhrGZxbOF6cNrC59K6dAyM3voKOd__s9mI-j8i5rbCrCTUJViiUnJTq2DKExT8KI_7erEKIfuwVf4IJ_oVioCEMkoZ9FOapB_cCAuhF-bHqQ2FbbZJGJnIKvSi_36GuSdNKAmjhb5OKXDaMre8XG9NRlu7bHnqO1JbfPlhYnyL8To6krBOponxK7pg4ELwsKLXSz7vop10FnDYPvIb7yxeqVZXciflXli4A9h85ghLwVtOhRfS_fPoNY3veqhHeuDtYPtWjDn5_QQ4iOmolk0eJu_qS9gkd-uPXXOJ3NZoep_cCz4Nfe8BfUA2TPmQbO97UfT1gE7bGr_lgG7T_VYuff2I_AwUD2jL8ICCwWlNMEWCaYdgKuHREjygV_ilDb-05dfP2NBLkV5alLSm1w1foZfanDp6aUMvfm-HXtrQSx29j8nB50_TyV4UGoxEKgXPI1KwKrE8i3dzMZbDfMhlhvKU6UgyI5QQWZYzOU6V0vAzS2OYMLlmcaZSHWue8OQJuVXa0jwjdBTzTOUyTROFpe1McJXpjDFjhFZ8yJ6Tp95ER3OvInNUG-_Fb0deks0W6Vfkdg7LlnkNe-Aqe-MQ-QVSYby0
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mexidol%2C+Cytoflavin%2C+and+succinic+acid+derivatives+as+antihypoxic%2C+anti-ischemic+metabolic+modulators%2C+and+ergogenic+aids+in+athletes+and+consideration+of+their+potential+as+performance+enhancing+drugs&rft.jtitle=Drug+testing+and+analysis&rft.au=J%C4%99drejko%2C+Karol&rft.au=Catlin%2C+Oliver&rft.au=Stewart%2C+Timothy&rft.au=Muszy%C5%84ska%2C+Bo%C5%BCena&rft.date=2024-12-01&rft.eissn=1942-7611&rft.volume=16&rft.issue=12&rft.spage=1436&rft_id=info:doi/10.1002%2Fdta.3655&rft_id=info%3Apmid%2F38403950&rft_id=info%3Apmid%2F38403950&rft.externalDocID=38403950